← Back to Search
Transscleral Drug Delivery For Posterior Segment Disease.
D. Geroski, H. Edelhauser
Published 2001 · Medicine
Download PDFAnalyze on Scholarcy
Exciting new treatments are being developed for retinal degenerations and posterior segment eye disease. The successful treatment of these visually devastating diseases will likely require delivering effective doses of pharmacologic agents to the posterior segment, possibly in conjunction with surgical or genetic interventions. Currently, the treatment of diseases affecting the posterior segment is limited by the difficulty in delivering effective doses of drugs to target tissues in the posterior vitreous, retina or choroid. This review summarizes recent laboratory and clinical studies that indicate that transscleral delivery of therapeutic solutes might be an effective means of achieving therapeutic concentrations of these agents in the posterior eye.
This paper references
Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.
T. Olsen (1995)
Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose.
O. Weijtens (2000)
Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit.
M. Barza (1977)
Measurement and Prediction of Transient Transport across Sclera for Drug Delivery to the Eye
M. Prausnitz (1998)
Pluronic F-127 gels as a vehicle for topical administration of anticancer agents.
S. Miyazaki (1984)
Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection.
O. Weijtens (1997)
Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.
M. Prausnitz (1998)
Dexamethasone concentration in vitreous and serum after oral administration.
O. Weijtens (1998)
Intraocular penetration of gentamicin after subconjunctibal and retrobulbar injection .
M. Barza (1978)
Human sclera: thickness and surface area.
T. Olsen (1998)
Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
I. Ahmed (1985)
Transscleral delivery of bioactive protein to the choroid and retina.
J. Ambati (2000)
MOVEMENT OF ALBUMIN AND DEXTRAN THROUGH THE SCLERA.
A. Bill (1965)
Diffusion of high molecular weight compounds through sclera.
J. Ambati (2000)
Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.
H. Edelhauser (1988)
Development of a local antibiotic delivery system using fibrin glue
B. Yu (1996)
Fiber matrix model of sclera and corneal stroma for drug delivery to the eye
A. Edwards (1998)
Proteoglycans and collagen fibre organization in human corneoscleral tissue.
M. S. Borcherding (1975)
Ocular drug delivery conventional ocular formulations
John C. Lang (1995)
The effect of intraocular pressure on human and rabbit scleral permeability.
D. E. Rudnick (1999)
High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.
O. Weijtens (1999)
Diffusion across the sclera.
D. Maurice (1977)
This paper is referenced by
Farmacologia ocular aplicada no tratamento de doenças do vítreo, retina e coróide
P. Filho (2010)
18 – Neurotrophic Cell Transplants for Degenerative Diseases of the Eye
C. Thanos (2007)
[Ocular pharmacology in the treatment of vitreous, retina and choroid diseases].
P. A. Filho (2010)
Evolving Role of Regional Depot Corticosteroids in Management of Diabetic Macular Edema
S. Kim (2017)
Microneedle-based minimally-invasive measurement of puncture resistance and fracture toughness of sclera.
S. H. Park (2016)
Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device.
C. Thanos (2004)
Extraocular muscle insertions relative to the fovea and optic nerve: humans and rhesus macaque.
X. Feng (2005)
Exogenous collagen cross-linking reduces scleral permeability: modeling the effects of age-related cross-link accumulation.
J. Stewart (2009)
A Review on Local Chemotherapy for Treatment of Retinoblastoma
F. Ghassemi (2011)
Influence of freeze-drying and γ-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol.
Gladys Rosario Ramos Yacasi (2016)
Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema
M. Cellini (2008)
Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye
V. Pillay (2016)
Drug Delivery to the Posterior Eye Using Etched Microneedles
Geetha Mahadevan (2011)
Differential effects of aging on transport properties of anterior and posterior human sclera.
O. Boubriak (2003)
Chapter 2 Design , Development and Evaluation of Nanoparticulate Based Carrier Systems for Ocular Drug delivery
Echography-Verified Retrobulbar Triamcinolone Injection in the Treatment of Uveitis
M. Gamal (2013)
Hydrogel-Forming Microneedle Arrays for Sustained and Controlled Ocular Drug Delivery
Maher Amer (2020)
Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-ε-caprolactone matrix.
Yongchun Meng (2014)
Dexamethasone distribution characteristic following controllable continuous sub-tenon drug delivery in rabbit
Xuetao Huang (2017)
Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.
Abeer M. Al-Ghananeem (2007)
Development of ophthalmic formulations
Paramita Bandyopadhyay (2016)
Triamcinolone Acetonide for the Treatment of Diabetic Macular Oedema
V. Sarao (2010)
Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery.
J. Cardillo (2010)
A drug delivery analysis of large molecules in ocular vitreous chamber: Dependency on saccadic movements after intravitreal injection.
M. Ferroni (2020)
Ultrasound-enhanced intrascleral delivery of protein.
Alex Cheung (2010)
Parameters affecting the transscleral delivery of two positively charged proteins of comparable size.
M. A. Grimaudo (2017)
Introduction: To evaluate the changes of scleral thickness after repeated intravitreal injections of bevacizumab in a consecutive series of patients with anterior segment optical coherence tomog-
Biopharmaceutical approaches for improved drug delivery across ocular barriers
Ketan Hippalgaonkar (2011)
A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Y. Choonara (2010)
Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development.
H. Gukasyan (2019)
Ocular Permeation Enhancers
N. Kim (2016)
Cholesterol-poly(ethylene) glycol nanocarriers for the transscleral delivery of sirolimus.
N. Elsaid (2014)See more